Brief: Maia Biotechnology Increased Maximum Aggregate Offering Price Of Shares Of Common Stock, Issuable Under At Market Offering Agreement
25/03/2024 20:12
March 25 (Reuters) - Maia Biotechnology Inc MAIA.A :
* MAIA BIOTECHNOLOGY - ON MARCH 25 INCREASED MAXIMUM
AGGREGATE
OFFERING PRICE OF SHARES OF COMMON STOCK, ISSUABLE UNDER AT
MARKET OFFERING AGREEMENT
* MAIA BIOTECHNOLOGY INC - INCREASED MAXIMUM AGGREGATE
OFFERING
PRICE OF SHARES OF COMMON STOCK FROM $1.4 MILLION 0 TO $4.95
MILLION
Source text for Eikon: [ID:https://bitly.ws/3gKwX]
Further company coverage: MAIA.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale